U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    MELK maternal embryonic leucine zipper kinase [ Homo sapiens (human) ]

    Gene ID: 9833, updated on 3-Apr-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses.

    Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses.
    Hameed Y.

    03/27/2024
    Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK-dependent manner.

    Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK‑dependent manner.
    Lee DY, Lee S, Kim YS, Park S, Bae SM, Cho EA, Park EJ, Park HH, Kim SY, So I, Chun JN, Jeon JH., Free PMC Article

    11/7/2023
    Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.

    Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.
    Xie X, Chauhan GB, Edupuganti R, Kogawa T, Park J, Tacam M, Tan AW, Mughees M, Vidhu F, Liu DD, Taliaferro JM, Pitner MK, Browning LS, Lee JH, Shen Y, Wang J, Ueno NT, Krishnamurthy S, Hortobagyi GN, Tripathy D, Van Laere SJ, Bartholomeusz G, Dalby KN, Bartholomeusz C., Free PMC Article

    07/3/2023
    ANKRD22 promotes glioma proliferation, migration, invasion, and epithelial-mesenchymal transition by upregulating E2F1-mediated MELK expression.

    ANKRD22 promotes glioma proliferation, migration, invasion, and epithelial-mesenchymal transition by upregulating E2F1-mediated MELK expression.
    Liu X, Zhao J, Wu Q, Wang L, Lu W, Feng Y.

    06/23/2023
    Differential Effects of Overexpression of Wild Type and Kinase-Dead MELK in Fibroblasts and Keratinocytes, Potential Implications for Skin Wound Healing and Cancer.

    Differential Effects of Overexpression of Wild Type and Kinase-Dead MELK in Fibroblasts and Keratinocytes, Potential Implications for Skin Wound Healing and Cancer.
    Szymański Ł, Lieto K, Zdanowski R, Lewicki S, Tassan JP, Kubiak JZ., Free PMC Article

    06/7/2023
    Circular RNA MELK Promotes Chondrocyte Apoptosis and Inhibits Autophagy in Osteoarthritis by Regulating MYD88/NF-kappaB Signaling Axis through MicroRNA-497-5p.

    Circular RNA MELK Promotes Chondrocyte Apoptosis and Inhibits Autophagy in Osteoarthritis by Regulating MYD88/NF-κB Signaling Axis through MicroRNA-497-5p.
    Zhang Y, Lu R, Huang X, Yin E, Yang Y, Yi C, You H, Song X, Yuan X., Free PMC Article

    09/17/2022
    LncRNA OSTM1-AS1 acts as an oncogenic factor in Wilms' tumor by regulating the miR-514a-3p/MELK axis.

    LncRNA OSTM1-AS1 acts as an oncogenic factor in Wilms' tumor by regulating the miR-514a-3p/MELK axis.
    Du J, Xiao J, Zhuo Y, Nie M, Yang J, Luo X, Gu H.

    08/27/2022
    Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer.

    Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer.
    Hardeman AA, Han YJ, Grushko TA, Mueller J, Gomez MJ, Zheng Y, Olopade OI., Free PMC Article

    07/2/2022
    xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade.

    xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade.
    Tang B, Zhu J, Liu F, Ding J, Wang Y, Fang S, Zheng L, Qiu R, Chen M, Shu G, Xu M, Lu C, Zhao Z, Yang Y, Ji J., Free PMC Article

    05/14/2022
    Up-regulation of MELK by E2F1 promotes the proliferation in cervical cancer cells.

    Up-regulation of MELK by E2F1 promotes the proliferation in cervical cancer cells.
    Sun H, Ma H, Zhang H, Ji M., Free PMC Article

    02/19/2022
    KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway.

    KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway.
    Shi J, Yang C, An J, Hao D, Liu C, Liu J, Sun J, Jiang J., Free PMC Article

    11/27/2021
    MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma.

    MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma.
    Tang Q, Li W, Zheng X, Ren L, Liu J, Li S, Wang J, Du G., Free PMC Article

    10/16/2021
    MELK/MPK38 in cancer: from mechanistic aspects to therapeutic strategies.

    MELK/MPK38 in cancer: from mechanistic aspects to therapeutic strategies.
    Thangaraj K, Ponnusamy L, Natarajan SR, Manoharan R.

    10/9/2021
    Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies.

    Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies.
    Jaune E, Cavazza E, Ronco C, Grytsai O, Abbe P, Tekaya N, Zerhouni M, Beranger G, Kaminski L, Bost F, Gesson M, Tulic M, Hofman P, Ballotti R, Passeron T, Botton T, Benhida R, Rocchi S., Free PMC Article

    10/2/2021
    High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo.

    High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo.
    Ikeda Y, Sato S, Yabuno A, Shintani D, Ogasawara A, Miwa M, Zewde M, Miyamoto T, Fujiwara K, Nakamura Y, Hasegawa K., Free PMC Article

    09/4/2021
    Suppression of long non-coding RNA PCAT19 inhibits glioma cell proliferation and invasion, and increases cell apoptosis through regulation of MELK targeted by miR-142-5p.

    Suppression of long non-coding RNA PCAT19 inhibits glioma cell proliferation and invasion, and increases cell apoptosis through regulation of MELK targeted by miR-142-5p.
    Xie YH, Hu J.

    08/28/2021
    Ectopic expression of MELK in oral squamous cell carcinoma and its correlation with epithelial mesenchymal transition.

    Ectopic expression of MELK in oral squamous cell carcinoma and its correlation with epithelial mesenchymal transition.
    Li B, Xu X, Bin X, Zhou J, Tang Z., Free PMC Article

    07/24/2021
    BUB1B Promotes Proliferation of Prostate Cancer via Transcriptional Regulation of MELK.

    BUB1B Promotes Proliferation of Prostate Cancer via Transcriptional Regulation of MELK.
    Tian JH, Mu LJ, Wang MY, Zeng J, Long QZ, Guan B, Wang W, Jiang YM, Bai XJ, Du YF.

    05/29/2021
    Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma.

    Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma.
    Jeddo SFA, Wei X, Li K, Li X, Yang Q, Dongol S, Li J., Free PMC Article

    05/22/2021
    MELK Accelerates the Progression of Colorectal Cancer via Activating the FAK/Src Pathway.

    MELK Accelerates the Progression of Colorectal Cancer via Activating the FAK/Src Pathway.
    Liu G, Zhan W, Guo W, Hu F, Qin J, Li R, Liao X.

    02/6/2021
    MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.

    MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
    Xu Q, Ge Q, Zhou Y, Yang B, Yang Q, Jiang S, Jiang R, Ai Z, Zhang Z, Teng Y., Free PMC Article

    10/3/2020
    MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40.

    MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40.
    Zhang H, Wei P, Lv W, Han X, Yang J, Qin S, Zhang Y., Free PMC Article

    09/19/2020
    MELK is a poor biomarker for non-small-cell lung carcinoma patients

    Higher maternal embryonic leucine zipper kinase mRNA expression level is a poor prognostic factor in non-small-cell lung carcinoma patients.
    Zang X, Qian C, Ruan Y, Xie J, Luo T, Xu B, Jiang J.

    07/4/2020
    We analyzed the expression of MELK and two putative targets, Forkhead Box M1 (FOXM1) and Enhancer of Zeste Homolog 2 (EZH2), in a collection of human iCCA by real-time RT-PCR and immunohistochemistry (IHC). The effects on iCCA growth of both the multi-kinase inhibitor OTSSP167 and specific small-interfering RNA (siRNA) against MELK were investigated in iCCA cell lines.

    Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma.
    Cigliano A, Pilo MG, Mela M, Ribback S, Dombrowski F, Pes GM, Cossu A, Evert M, Calvisi DF, Utpatel K., Free PMC Article

    06/13/2020
    These findings uncover an important role of MELK and USP36 in mediating EZH2 stability in extranodal natural killer/T-cell lymphoma (NKTL). Moreover, MELK overexpression led to decreased sensitivity to bortezomib treatment in NKTL based on deprivation of EZH2 ubiquitination.

    MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma.
    Li B, Yan J, Phyu T, Fan S, Chung TH, Mustafa N, Lin B, Wang L, Eichhorn PJA, Goh BC, Ng SB, Kappei D, Chng WJ.

    03/21/2020
    firstprevious page of 3 nextlast